Coastal Financial Corporation (CCB) vs Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII)
A side-by-side comparison of Coastal Financial Corporation and Drugs Made In America Acquisition II Corp. Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
Total return — CCB vs DMII
growth of $100 · dividends reinvested · last 1yCCB vs DMII: by the numbers
- •DMII is the larger company ($649M vs $624M market cap).
- •Both run net losses; DMII's is the smaller (0.00% vs -0.49% net margin).
Metrics side by side
Valuation
| Metric | CCB | DMII |
|---|---|---|
| P/E ratio | N/A | 34.78 |
| Forward P/E | 30.71 | N/A |
| P/S ratio | 0.79 | N/A |
| P/B ratio | 1.35 | 1.31 |
Profitability
| Metric | CCB | DMII |
|---|---|---|
| Gross margin | N/A | 0.00% |
| Operating margin | 11.35% | 0.00% |
| Net margin | -0.49% | 0.00% |
| ROE | -0.83% | 2.62% |
| ROIC | N/A | -0.28% |
Coastal Financial Corporation: Gross margin is not shown for a lender or insurer: its revenue is interest, premiums and fees rather than the sale of goods, so there is no cost of goods sold to measure it against.
Growth (annualized)
| Metric | CCB | DMII |
|---|---|---|
| Revenue CAGR (5Y) | 56.97% | N/A |
| EPS CAGR (5Y) | 19.70% | N/A |
| Total return CAGR (5Y) | 5.06% | N/A |
Go deeper
Dig into the metrics
Coastal Financial & Drugs Made In America Acquisition II Corp. Ordinary Shares appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.